MicroX Labs is a brand that strives to improve health and survival rates in cancer care. They offer a revolutionary solution called HomeCyte TM, which is a portable, point-of-care blood analyzer. This innovative device allows frequent monitoring of infection levels and internal bleeding evaluation associated with oncology treatments.

The HomeCyte TM solution consists of several hardware components, including a portable reader device, cartridges with integrated cell flow, and a microfluidics impedance cytometer for measuring cellular information. It also utilizes algorithmics and machine learning classifiers for accurate diagnostics. The benefits of HomeCyte TM are numerous, including reducing the risk of hospital infections, providing comfort by allowing patients to stay at home or receive care at point-of-care facilities, saving costs by minimizing hospital visits, and offering instant medical help that can significantly impact a patient's survival rate.

With its versatility and time-saving features, HomeCyte TM is a valuable tool for both patients and healthcare providers. MicroX Labs is dedicated to advancing cancer care through innovation and cutting-edge technology